UPDATE
$YS Biopharma(YS.US$ YS Biopharma Has Enrolled The First Subject In Its Phase 3 Trial Of Its PIKA Rabies Vaccine. The Trial Is Expected To Include An Estimated 4,500 Subjects![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
